Adrenocortical corticotropic insufficiency secondary to the use of cosmetic dermocorticoids

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Jan 23, 2020
DOI: https://doi.org/10.22551/2019.25.0604.10158
Annelie Kérékou Hodé Hubert Dédjan

Abstract

Voluntary depigmentation or artificial depigmentation for cosmetic purposes is a very widespread phenomenon in Africa. The prevalence reported by several authors varies from 26 to 67%. The complications linked to their use are numerous and less known by the population. We report two cases of acute adrenocortical insufficiency secondary to the use of cosmetic dermocorticoids in diabetic patients aged 40 and 53 years respectively. They were admitted with signs of ketoacidosis decompensation which were similar to signs of acute adrenal insufficiency. The cases history revealed that they were using dermocorticoids. The clinical examination identified in both patients a systemic inflammatory response syndrome and general depigmentation. The 40-year-old patient had erysipelas of the left leg and the 53-year-old patient had a diabetic foot with a neuropathic and infectious mechanism. Laboratory tests revealed hyperglycemia, massive acetonuria and a low 8-hour cortisol. The clinical outcome was favorable after hydro-electrolytic rehydration, hourly intravenous insulin therapy, hydrocortisone and antibiotic therapy. Corticotropic insufficiency secondary to voluntary depigmentation by dermocorticoids is a complication that should be systematically sought in any subject using dermocorticoids. Hydrocortisone substitution should be done without delay in the event of confirmed corticotropic insufficiency.

##plugins.themes.bootstrap3.article.details##

Keywords

corticotropic adrenal insufficiency, dermocorticoids, voluntary depigmentation, diabetes, hydrocortisone

References
1. Dadzie OE, Petit A. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents. JEADV 2009; 23(7):741-750.
2. Faye O, Keita S, Diakité FS, Konaré HD, Ndiaye HT. Side effects of de-pigmenting products in Bamako, Mali. Int J Dermatol 2005; 44(Suppl. 1):35-36.
3. Ajose FOA. Consequences of skin bleaching in Nigerian men and women. Int J Dermatol 2005; 44(Suppl. 1):41-43.
4. Traoré A, Kadéba JC, Niamba P, Barro F, Ouedraogo L.. Use of cutaneous depigmenting products by women in two towns in Burkina Faso: epidemiologic data, motivations, products and sides effects. Int J Dermatol 2005; 44(Suppl. 1):30-32.
5. Adebajo SB. An epidemiological survey of the use of cosmetic skin lightening cosmetics among traders in Lagos, Nigeria. West Afr J Med 2002; 21(1):51-55.
6. Pitché P, Kombaté K, Tchangai-Walla K. Cosmetic use of skin-bleaching products and associated complications. Int J Dermatol 2005; 44(Suppl. 1):39-40.
7. Sène D, Huong-Boutin DLT, Thiollet M, Barete S, Cacoub P, Piette JC. Insuffisance surrénalienne haute symptomatique compliquant lusage de dermocorticoïdes pour dépigmentation volontaire. Rev Méd Interne 2008; 29(12):1030-1033.
8. Kouotou EA, Bissek AZ, Nouind CC, Defo D, Sieleunou I, Ndam EC. Dépigmentation volontaire: pratiques et dermatoses associées chez les commerçantes de Yaoundé (Cameroun). Ann Dermatol Venerol 2015; 142(6-7):443-445.
9. Lewin C, Malbach HI. Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. Am J Clin Dermatol 2002; 3(3):141-147.
10. Ladizinski B, Mistry N, Kundu RV. Widespread use of toxic skin lightening compounds: Medical and psychosocial aspects. Dermatol Clin 2011; 29(1):111-123.
11. Boëkle B, Jara D, Nindi W, Aberer W, Sepp NT. Adrenal insufficiency as a result of long-term misuse of topical corticosteroids. Dermatology 2014; 228(4):289-293.
12. Boyle J, Kennedy CT. Hydroquinone concentrations in skin lightening creams.Br J Dermatol 1986; 114(4):501-504.
13. Perret JL, Sane M, Gning S, Ba K, Rohou G. Hypothalamo-hypophyseal-adrenal hypo-function caused by the use of bleaching cosmetics in Senegal. Bull Soc Pathol Exot 2001; 94:249-252.
14. Sobngwi E, Lubin V, Ury P, et al. Insuffisance corticotrope et diabète sucré secondaire à lusage des dermocorticoïdes à visée cosmétiques. Ann Endocrinol 2003; 64:203-204.
15. Raynaud E, Cellier C, Perret JL. Dépigmentation cutanée à visée cosmétique: Enquête de prévalence et effets indésirables dans une population féminine sénégalaise. Ann Dermatol Venerol 2001; 128(6-7):720-724.
How to Cite
Hodé, A. K., & Dédjan, H. (2020). Adrenocortical corticotropic insufficiency secondary to the use of cosmetic dermocorticoids. Archive of Clinical Cases, 6(4), Arch Clin Cases 2019; 6(4):81-84. https://doi.org/10.22551/2019.25.0604.10158
Issue
Vol. 6 No. 4 (2019)
Section
Case Reports

Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.

Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.

Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.

How to Cite

Hodé, A. K., & Dédjan, H. (2020). Adrenocortical corticotropic insufficiency secondary to the use of cosmetic dermocorticoids. Archive of Clinical Cases, 6(4), Arch Clin Cases 2019; 6(4):81-84. https://doi.org/10.22551/2019.25.0604.10158